huC242-DM4: Interim Phase I data

Interim data from a dose-escalation Phase I trial showed that the half-life

Read the full 120 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE